Replies to post #42275 on Biotech Values

[DewDiligence]

>Didn't NRPH negotiate a partnership deal with Shire that gave NRPH something like 60% or 70% of Vyvanse sales?<

The economics of the partnership varied greatly depending on the ultimate DEA scheduling of NRP104.